Comparing rigid and deformable dose registration for high dose thoracic re-irradiation
Authors:
- Sashendra SenthiSSSashendra Senthi
- Gwendolyn H.M.J. GriffioenGGGwendolyn H.M.J. Griffioen
- John R. van Sörnsen de KosteJKJohn R. van Sörnsen de Koste
- Ben J. SlotmanBSBen J. Slotman
- Suresh SenanSSSuresh Senan
- 1 March 2013
- journal article
- research article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 106 (3) , 323-326
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Consideration of Dose Limits for Organs at Risk of Thoracic Radiotherapy: Atlas for Lung, Proximal Bronchial Tree, Esophagus, Spinal Cord, Ribs, and Brachial PlexusInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Sequential vs Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer: Randomized Phase III Trial RTOG 9410JNCI: Journal of the National Cancer Institute, 2011
- Clinical prognostic factors in patients with locally advanced (stage III) nonsmall cell lung cancer treated with hyperfractionated radiation therapy with and without concurrent chemotherapyCancer, 2011
- Radiotherapy as Adjuvant Therapy and Salvage Therapy After Resection of Non-Small Cell Lung CancerRadiation Medicine Rounds, 2010
- Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trialThe Lancet, 2009
- Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic OutcomesThe Annals of Thoracic Surgery, 2008
- Assessment of a Model-Based Deformable Image Registration Approach for Radiation Therapy PlanningInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Reirradiation for locally recurrent lung cancer previously treated with radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Nonrigid multimodality image registration2001
- Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trialRadiotherapy and Oncology, 1999